People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ocaro Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $5.8M | $6.6M | 2009 |
| Blue Sentry, Inc. | — | Other Technology | Seed | $3.1M | $24.4M | 2016 |
THOMAS R. SLOAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside THOMAS R. SLOAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ERIC BARNETT | 1 | 2 |
| LUTHER H. HODGES, JR. | 1 | 2 |
| KENNETH YATES | 1 | 1 |
| ANDY JANE | 1 | 1 |
| James H. Bingham, Jr. | 1 | 1 |
| Chandler C. Prosser | 1 | 1 |
| Kenneth N. Johnson, Jr. | 1 | 1 |
| Herbert H. Patrick, Jr. | 1 | 1 |
| James David Sink | 1 | 1 |
| Roland Johnson | 1 | 1 |
| Lanty Smith | 1 | 1 |
| Bill Yates | 1 | 1 |
| ROLAND H. JOHNSON | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.